tiprankstipranks
Advertisement
Advertisement
Aggressive Treg-Modulating Immunology Strategy and Advancing Clinical Execution Underpin Buy Rating on Coya in ALS and FTD
PremiumRatingsAggressive Treg-Modulating Immunology Strategy and Advancing Clinical Execution Underpin Buy Rating on Coya in ALS and FTD
19d ago
Coya Therapeutics Announces Strategic Private Placement Financing
Premium
Company Announcements
Coya Therapeutics Announces Strategic Private Placement Financing
2M ago
Coya Therapeutics to sell 2.522M shares at $4.40 in private placement
Premium
The Fly
Coya Therapeutics to sell 2.522M shares at $4.40 in private placement
2M ago
Coya Therapeutics announces FDA acceptance of COYA 302 IND application
PremiumThe FlyCoya Therapeutics announces FDA acceptance of COYA 302 IND application
3M ago
Coya Therapeutics: Clinical Momentum, Extended Cash Runway, and DCF-Derived Upside Support Reiterated Buy and $18 Target
Premium
Ratings
Coya Therapeutics: Clinical Momentum, Extended Cash Runway, and DCF-Derived Upside Support Reiterated Buy and $18 Target
3M ago
Coya announces Health Canada acceptance of COYA 302 clinical trial application
Premium
The Fly
Coya announces Health Canada acceptance of COYA 302 clinical trial application
3M ago
Coya Therapeutics: Strong Financial Position and Upcoming Catalysts Support Buy Rating
PremiumRatingsCoya Therapeutics: Strong Financial Position and Upcoming Catalysts Support Buy Rating
4M ago
Coya Therapeutics Reports Q3 2025 Financial Results
Premium
Company Announcements
Coya Therapeutics Reports Q3 2025 Financial Results
5M ago
Coya Therapeutics reports Q3 EPS (13c), consensus (30c)
Premium
The Fly
Coya Therapeutics reports Q3 EPS (13c), consensus (30c)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100